Comparing Pulsed Field Ablation and Cryoballoon for Atrial Fibrillation Treatment
Author Information
Author(s): Giampaolo Vetta, Domenico Giovanni Della Rocca, Antonio Parlavecchio, Michele Magnocavallo, Antonio Sorgente, Luigi Pannone, Alvise Del Monte, Alexandre Almorad, Juan Sieira, Lorenzo Marcon, Ioannis Doundoulakis, Sanghamitra Mohanty, Charles Audiat, Kazutaka Nakasone, Gezim Bala, Erwin Ströker, Stéphane Combes, Ingrid Overeinder, Stefano Bianchi, Pietro Palmisano, Pietro Rossi, Serge Boveda, Marc La Meir, Andrea Natale, Andrea Sarkozy, Carlo de Asmundis, Gian-Battista Chierchia
Primary Institution: Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel
Hypothesis
Is pulsed field ablation more effective and safer than cryoballoon ablation for atrial fibrillation?
Conclusion
Pulsed field ablation showed higher acute procedural success and a better safety profile compared to cryoballoon ablation.
Supporting Evidence
- Pulsed field ablation achieved 99.9% acute procedural success on a vein basis compared to 99.1% for cryoballoon.
- Pulsed field ablation had lower overall periprocedural complications (3.1% vs. 5.6%).
- Pulsed field ablation demonstrated shorter procedural time (75.9 min vs. 105.6 min).
- Pulsed field ablation showed shorter fluoroscopy time (14.2 min vs. 18.9 min).
- Freedom from atrial tachyarrhythmias at 1 year was similar between both methods (82.3% vs. 80.3%).
Takeaway
Pulsed field ablation is a new way to treat heart rhythm problems that works better and is safer than the older cryoballoon method.
Methodology
A systematic review and meta-analysis comparing pulsed field ablation and cryoballoon ablation for atrial fibrillation.
Potential Biases
Potential biases due to non-contemporaneous study designs and varying confirmation methods for procedural success.
Limitations
The analysis included observational studies, which may introduce biases, and there was high heterogeneity in outcomes.
Participant Demographics
Pulsed field ablation patients were 65.9% male, average age 65.3 years; cryoballoon patients were 65.8% male, average age 62.4 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 99.8–100
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website